Horizon Therapeutics (United States)
- Research works
- 97 ▲ 444% vs 2013–17
- Citations
- 1.7k 17.3 per fractional work
- Top-10% rate
- 8.5% record average 16.5%
- Open access
- 71% world 28%
Not ranked overall: Horizon Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.4×. Every wedge is a field page.
- Immunology and Microbiology 4.4×
- Medicine 4.2×
- Veterinary 2.0×
- Biochemistry, Genetics and Molecular Biology 1.7×
- Pharmacology, Toxicology and Pharmaceutics 1.2×
- Nursing 0.8×
- Neuroscience 0.6×
- Psychology 0.3×
- Social Sciences 0.1×
- Chemistry 0.1×
- Materials Science 0.1×
- Health Professions 0.1×
- Mathematics 0.1×
- Engineering 0.0×
- Environmental Science 0.0×
- Agricultural and Biological Sciences 0.0×
Who are the top researchers at Horizon Therapeutics (United States)?
Ranked on the composite score, Brian LaMoreaux lead among researchers whose main affiliation is Horizon Therapeutics (United States).
- 1 Brian LaMoreaux United States · #1,214,648 worldwide 22 citations · 17 works
Which keywords describe research at Horizon Therapeutics (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cardiovascular Risk, Inflammation, Endothelial Dysfunction, Metabolic Syndrome, Hypertension, Hyperuricemia, Gout and Uric Acid.
- Neurological Disorders
- Graves' Ophthalmopathy
- Fc Receptors
- Systemic Sclerosis
- Cancer
- Hepatitis C Virus
- Saliva
- Diagnosis
- Lymphoma
- Autoimmunity
- Glycosylation
- Autoimmune Disease
- Diagnostic Criteria
- Thyroid Hormone
- Management
- Epidemiology
- Uric Acid
- Hyperuricemia
- Metabolic Syndrome
- Inflammation
- Cardiovascular Risk
- Endothelial Dysfunction
- Hypertension
- Gout
- Treatment
- Autoantibodies
- Thyroid Dysfunction
- Biomarkers
- Fibrosis
- Immune Response
- Monoclonal Antibodies
- Immunosuppressive Therapy
- Therapeutic Antibodies
- Liver Disease
- Salivary Gland
- Ribavirin
- Pulmonary Involvement
- Antibody Engineering
- TGF-ß
- Thyroid-Associated Ophthalmopathy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cardiovascular Risk11▲ 90×3 topics
- Inflammation11▲ 13×11 topics
- Endothelial Dysfunction10▲ 105×2 topics
- Metabolic Syndrome9▲ 28×4 topics
- Hypertension9▲ 74×2 topics
- Hyperuricemia9▲ 877×2 topics
- Gout8▲ 1093×1 topic
- Uric Acid8▲ 1093×1 topic
- Treatment6▲ 13×11 topics
- Epidemiology3▲ 2.2×14 topics
- Autoantibodies3▲ 32×6 topics
- Management3▲ 8.4×6 topics
- Thyroid Dysfunction3▲ 210×1 topic
- Thyroid Hormone3▲ 210×1 topic
- Biomarkers2▲ 8.6×6 topics
- Diagnostic Criteria2▲ 24×3 topics
- Fibrosis2▲ 29×3 topics
- Autoimmune Disease2▲ 83×3 topics
- Immune Response2▲ 8.9×5 topics
- Glycosylation2▲ 42×3 topics
- Monoclonal Antibodies2▲ 52×3 topics
- Autoimmunity2▲ 32×3 topics
- Immunosuppressive Therapy2▲ 24×4 topics
- Lymphoma2▲ 28×2 topics
- Therapeutic Antibodies2▲ 66×2 topics
- Diagnosis2▲ 4.6×7 topics
- Liver Disease2▲ 43×2 topics
- Saliva2▲ 173×1 topic
- Salivary Gland2▲ 173×1 topic
- Hepatitis C Virus2▲ 108×1 topic
- Ribavirin2▲ 108×1 topic
- Cancer1▲ 2.5×8 topics
- Pulmonary Involvement1▲ 91×1 topic
- Systemic Sclerosis1▲ 91×1 topic
- Antibody Engineering1▲ 57×1 topic
- Fc Receptors1▲ 57×1 topic
- TGF-ß1▲ 19×3 topics
- Graves' Ophthalmopathy1▲ 152×1 topic
- Thyroid-Associated Ophthalmopathy1▲ 152×1 topic
- Neurological Disorders1▲ 4.6×4 topics
Which research topics does Horizon Therapeutics (United States) publish most on?
By volume in 2022–2025: Gout, Hyperuricemia, Uric Acid, Thyroid Disorders and Treatments, Salivary Gland Disorders and Functions and Hepatitis C virus research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Gout, Hyperuricemia, Uric Acid Nephrology 8 works
- 2 Thyroid Disorders and Treatments Endocrinology, Diabetes and Metabolism 3 works
- 3 Salivary Gland Disorders and Functions Physiology 2 works
- 4 Hepatitis C virus research Hepatology 2 works
- 5 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 1 works
- 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 7 Ophthalmology and Eye Disorders Pathology and Forensic Medicine 1 works
- 8 Social Media in Health Education Health 1 works
- 9 Systemic Lupus Erythematosus Research Rheumatology 1 works
- 10 Case Reports on Hematomas Surgery 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Horizon Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 444% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Lake Forest
- Lake Forest College
- Brunswick (United States)
- IDEX Corporation (United States)
- Associated Research (United States)
- Northwestern Medicine Lake Forest Hospital
- Lake Forest Academy
- Lake Forest Graduate School of Management
- Vyaire Medical (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.